Stock Markets April 8, 2026 09:12 AM

Arxis Sets IPO Range Aiming for $11.2 Billion Valuation

Aerospace components manufacturer files for U.S. listing as defense tech deals draw market attention amid geopolitical volatility

By Maya Rios
Arxis Sets IPO Range Aiming for $11.2 Billion Valuation

Arxis, a Bloomfield, Connecticut-based maker of electronic and mechanical components for aerospace, defense, medical technology and specialized industrial markets, has filed for a U.S. initial public offering seeking up to $1.06 billion. The company is offering 37.7 million shares at $25 to $28 each, targeting a valuation of as much as $11.2 billion. Proceeds are intended to reduce debt and support working capital and other corporate needs.

Key Points

  • Arxis is seeking up to $1.06 billion by offering 37.7 million shares at $25 to $28, targeting an up-to-$11.2 billion valuation.
  • Proceeds from the offering are planned to pay down debt, with remaining funds to be used for working capital and other corporate purposes; the company operates two reportable segments: electronic components and mechanical components.
  • Institutional interest of up to $400 million has been indicated by several asset managers; Goldman Sachs, Morgan Stanley and Jefferies are joint bookrunners and the company will list on Nasdaq under the symbol ARXS.

Arxis has filed for a U.S. initial public offering with a target valuation of up to $11.2 billion, the aerospace parts and components manufacturer said on Wednesday. The Bloomfield, Connecticut-based company plans to sell 37.7 million shares in the offering, with the share price set in a range of $25 to $28, for proceeds of up to $1.06 billion.

The company, backed by private equity firm Arcline Investment Management, develops and manufactures both electronic and mechanical components that serve aerospace and defense customers as well as medical technology and specialized industrial markets. Arxis reports operations across two segments defined by product type - electronic components and mechanical components.

Arxis disclosed that it intends to use the funds raised to pay down outstanding debt, and to allocate the remaining proceeds toward working capital and other general corporate purposes. Arcline, the private equity sponsor, focuses on industrial-sector investments and continues to hold a supporting role in the transaction.

Several institutional investors have separately indicated interest in taking a portion of the offering. Funds and accounts managed by Capital International Investors, Capital Research Global Investors, Janus Henderson Investors and T. Rowe Price Investment Management have signaled they may buy up to a combined total of $400 million of shares from the IPO.

Goldman Sachs, Morgan Stanley and Jefferies are serving as the joint bookrunning managers for the offering. Upon completion of the IPO, Arxis plans to list on the Nasdaq exchange under the ticker symbol "ARXS."

The filing comes amid increased market attention on defense-related technology listings following a period of heightened volatility linked to the U.S.-Israeli war on Iran. Bankers have recently shown greater interest in taking defense tech and related companies public, viewing such listings as potentially more resilient in the current environment. Recent weeks have also seen filings from other defense- and precision-focused companies, including drone maker AEVEX and precision components manufacturer Elmet.


Contextual note - The information above reflects the details disclosed in Arxis' IPO filing, including the stated use of proceeds, investor indications of interest, and the identities of the bookrunning banks. Where projections or interests are described, they are reported as indicated in the filing and not as guarantees of future results.

Risks

  • Market volatility linked to geopolitical conflict - the filing notes that higher volatility following the U.S.-Israeli war on Iran has influenced bankers toward defense tech listings, creating uncertainty for broader IPO market dynamics.
  • Reliance on IPO proceeds to reduce debt - the company intends to pay down debt with offering proceeds, which exposes its balance sheet strategy to the outcome and size of the offering.
  • Indications of investor interest are not guarantees - while several funds have indicated potential participation up to $400 million, such indications do not ensure those purchases will materialize.

More from Stock Markets

Warsaw Stocks Climb to New High as WIG30 Surges 3.50% Apr 8, 2026 Casablanca Market Climbs as Banking, Beverage and Transport Stocks Lead Gains Apr 8, 2026 Oslo OBX Falls 3.16% as Energy Majors Suffer Large Losses Apr 8, 2026 Athens Market Surges; Broad Gains Lift Index to One-Month Peak Apr 8, 2026 Rio Tinto and Century Aluminum Raise U.S. Billet Premiums by About 12% Apr 8, 2026